JP2024546667A5 - - Google Patents
Info
- Publication number
- JP2024546667A5 JP2024546667A5 JP2024533904A JP2024533904A JP2024546667A5 JP 2024546667 A5 JP2024546667 A5 JP 2024546667A5 JP 2024533904 A JP2024533904 A JP 2024533904A JP 2024533904 A JP2024533904 A JP 2024533904A JP 2024546667 A5 JP2024546667 A5 JP 2024546667A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111575800 | 2021-12-21 | ||
| CN202111575800.2 | 2021-12-21 | ||
| PCT/CN2022/139942 WO2023116607A1 (zh) | 2021-12-21 | 2022-12-19 | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024546667A JP2024546667A (ja) | 2024-12-26 |
| JPWO2023116607A5 JPWO2023116607A5 (https=) | 2025-12-24 |
| JP2024546667A5 true JP2024546667A5 (https=) | 2025-12-24 |
Family
ID=86901326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533904A Pending JP2024546667A (ja) | 2021-12-21 | 2022-12-19 | 核酸、当該核酸を含む組成物及び複合体並びに調製方法と使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250057870A1 (https=) |
| EP (1) | EP4455284A1 (https=) |
| JP (1) | JP2024546667A (https=) |
| KR (1) | KR20240117104A (https=) |
| CN (1) | CN118202049A (https=) |
| AU (1) | AU2022422864A1 (https=) |
| CA (1) | CA3242059A1 (https=) |
| WO (1) | WO2023116607A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020280438B2 (en) | 2019-05-22 | 2025-03-06 | Suzhou Ribo Life Science Co., Ltd. | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use |
| JP7610268B2 (ja) | 2019-05-22 | 2025-01-08 | スーチョウ リボ ライフ サイエンス カンパニー、リミテッド | 核酸、薬物組成物及び複合体ならびに調製方法と使用 |
| WO2020233680A1 (zh) | 2019-05-22 | 2020-11-26 | 苏州瑞博生物技术股份有限公司 | 核酸、药物组合物与缀合物及制备方法和用途 |
| EP3978609A4 (en) | 2019-05-24 | 2024-02-07 | Suzhou Ribo Life Science Co., Ltd. | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use |
| CN121780524A (zh) * | 2024-08-02 | 2026-04-03 | 北京尧景基因技术有限公司 | 抑制MAPT基因表达的siRNA及其缀合物和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009143371A2 (en) * | 2008-05-21 | 2009-11-26 | Intradigm Corporation | COMPOSITIONS COMPRISING mTOR SIRNA AND METHODS OF USE THEREOF |
| WO2010064851A2 (ko) * | 2008-12-02 | 2010-06-10 | 울산대학교 산학협력단 | 종간 교차활성을 지닌 ｍＴＯＲ을 표적으로 하는 ｓｉＲＮＡ, 이를 포함하는 재조합벡터 및 이를 함유하는 약학조성물 |
| US20120136073A1 (en) | 2010-11-15 | 2012-05-31 | Life Technologies Corporation | Amine-Containing Transfection Reagents and methods for making and using same |
| WO2017151732A1 (en) * | 2016-03-02 | 2017-09-08 | Beth Israel Deaconess Medical Center Technology Venture Office, Br2 | Therapeutic targets for lin-28-expressing cancers |
| AU2018216509B2 (en) * | 2017-01-31 | 2024-02-29 | Curigin Co.,Ltd. | Nucleic acid simultaneously inhibiting expression of mTOR gene and STAT3 gene |
| TN2019000308A1 (en) | 2017-07-06 | 2021-05-07 | Arrowhead Pharmaceuticals Inc | RNAi AGENTS FOR INHIBITING EXPRESSION OF ALPHA-ENaC AND METHODS OF USE |
| WO2019105437A1 (zh) | 2017-12-01 | 2019-06-06 | 苏州瑞博生物技术有限公司 | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 |
| EP3732185B1 (en) | 2017-12-29 | 2025-02-26 | Suzhou Ribo Life Science Co., Ltd. | Conjugates and preparation and use thereof |
| WO2019217459A1 (en) | 2018-05-07 | 2019-11-14 | Alnylam Pharmaceuticals, Inc. | Extrahepatic delivery |
| WO2020018461A1 (en) * | 2018-07-16 | 2020-01-23 | The University Of Virginia Patent Foundation | Compositions and methods of diagnosis and treatment for neurological diseases |
| CN112423795A (zh) * | 2018-12-28 | 2021-02-26 | 苏州瑞博生物技术股份有限公司 | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 |
-
2022
- 2022-12-19 AU AU2022422864A patent/AU2022422864A1/en active Pending
- 2022-12-19 EP EP22909920.5A patent/EP4455284A1/en active Pending
- 2022-12-19 CN CN202280068763.2A patent/CN118202049A/zh active Pending
- 2022-12-19 KR KR1020247021150A patent/KR20240117104A/ko active Pending
- 2022-12-19 JP JP2024533904A patent/JP2024546667A/ja active Pending
- 2022-12-19 US US18/722,280 patent/US20250057870A1/en active Pending
- 2022-12-19 WO PCT/CN2022/139942 patent/WO2023116607A1/zh not_active Ceased
- 2022-12-19 CA CA3242059A patent/CA3242059A1/en active Pending